Home » Seminars » Plasma biomarkers for the diagnosis of Alzheimer’s disease (AD). A game changer.

Plasma biomarkers for the diagnosis of Alzheimer’s disease (AD). A game changer.

Pascual Sánchez Juan

Fundación Centro de Investigación de Enfermedades Neurológicas (CIEN, Madrid)

06 Feb 2023 13:00

Aketxe Room, Sede Building, Leioa

Import this event to your agenda

During my presentation, I will discuss the diagnostic conceptualization of AD as a biological entity and the main “core” AD biomarkers on which this model has been based. I will then review the recent developments that have allowed AD plasma biomarkers to be available in the last two years. These new techniques are promising, as they correlate very well with the CSF determinations but have the advantage of great scalability, which would make mass screenings possible. In any case, there are still important challenges before these new methods arrive at the clinic. I will focus on some of the studies we are carrying out in CIEN and other studies like the Valdecilla cohort trying to answer some of these questions.